Cure Alzheimer's Fund is very appreciative of the continuing commitment of Congress and President Obama reaffirmed by the approval of increased funding for Alzheimer's disease research. The additional $350 million for NIH included in the tax and spending bill signed into law is a tremendous step toward the $2 billion a year experts, including members of the Cure Alzheimer's Fund Research Consortium, have said is necessary to effectively treat or prevent Alzheimer's disease by 2025.
Andrew B. and Gretchen P. Jones Professor and Chairman, Department of Neurology (primary); Professor of Developmental Biology; Director, Hope Center for Neurological Disorders and Hope Center Program on Protein Aggregation and Neurodegeneration; Associate Director, Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis
As our research “bench” continues to grow, we’re thrilled to welcome two new Research Consortium and two new Scientific Advisory Board members to our team. Each member brings unique expertise to accelerate our progress toward a cure.
With 10 years of research behind us, Cure Alzheimer’s Fund continues to grow, with the quality of our research remaining extraordinary. To build on our success, we recently welcomed four new Research Consortium members and four new employees to our organization.
Cure Alzheimer's Fund is pleased to see the passage of the 21st Centuries Cures Act in the House of Representatives. The overwhelming bipartisan support for the bill shows the need for legislation to improve the process of getting to cures for life-threatening diseases like Alzheimer's.